Janssen Pharmaceutica is part of Johnson & Johnson, the largest healthcare company in the world with more than 265 operational companies in 60 countries and more than 128,000 employees. J&J has activities in consumer products, medical devices and pharmaceuticals. The Johnson & Johnson pharmaceutical activities operate under one name: Janssen Pharmaceutical Companies of Johnson & Johnson.
Janssen’s R&D centers develop products for a wide range of disease areas: mental disorders, neurological problems, infectious diseases, immunological disorders, cancer, and cardiovascular and metabolic conditions. In the Netherlands we are based in Leiden and Breda, while we also have a large R&D site in Beerse, Belgium, just 15 kilometers across the Dutch border. The full breadth of activities from research, development, clinical studies, manufacturing, logistics and patient access to innovative medicines are all based in this region.